Correlation Between Tscan Therapeutics and Valneva SE
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Valneva SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Valneva SE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and Valneva SE ADR, you can compare the effects of market volatilities on Tscan Therapeutics and Valneva SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Valneva SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Valneva SE.
Diversification Opportunities for Tscan Therapeutics and Valneva SE
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Tscan and Valneva is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Valneva SE ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valneva SE ADR and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Valneva SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valneva SE ADR has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Valneva SE go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and Valneva SE
Given the investment horizon of 90 days Tscan Therapeutics is expected to generate 1.56 times more return on investment than Valneva SE. However, Tscan Therapeutics is 1.56 times more volatile than Valneva SE ADR. It trades about -0.23 of its potential returns per unit of risk. Valneva SE ADR is currently generating about -0.41 per unit of risk. If you would invest 509.00 in Tscan Therapeutics on August 24, 2024 and sell it today you would lose (115.00) from holding Tscan Therapeutics or give up 22.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tscan Therapeutics vs. Valneva SE ADR
Performance |
| Timeline |
| Tscan Therapeutics |
| Valneva SE ADR |
Tscan Therapeutics and Valneva SE Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tscan Therapeutics and Valneva SE
The main advantage of trading using opposite Tscan Therapeutics and Valneva SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Valneva SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will offset losses from the drop in Valneva SE's long position.| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
| Valneva SE vs. Lyra Therapeutics | Valneva SE vs. Hookipa Pharma | Valneva SE vs. Cingulate Warrants | Valneva SE vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |